Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Cognitive Screening with the Montreal Cognitive Assessment

Purpose and Interpretation

  • The Montreal Cognitive Assessment (MoCA) is a reliable screening tool that is more sensitive than the Mini-Mental State Examination (MMSE) for detecting mild cognitive impairment (MCI), particularly early in disease progression, and should be used when MCI is suspected or when there is concern about cognitive status despite a "normal" MMSE score, according to the American Academy of Neurology 1
  • The MoCA provides a comprehensive assessment of cognitive function, including attention, executive functions, and visuospatial abilities that are often impaired in various cognitive disorders, as noted by the National Institute of Neurological Disorders and Stroke 2, 3
  • The MoCA helps distinguish between normal cognition, MCI, and dementia, which is clinically important for treatment planning and prognosis, as recommended by the American Geriatrics Society 1

Clinical Applications and Recommendations

  • The MoCA is recommended when mild cognitive impairment is suspected or when there is concern about cognitive status despite a "normal" MMSE score, particularly for patients with a history of stroke or transient ischemic attack, according to the American Heart Association 1
  • The MoCA is useful for evaluating patients with late-onset depressive disorder or lifetime history of major depression, as suggested by the American Psychiatric Association 6
  • The MoCA demonstrates higher sensitivity compared to the MMSE for detecting vascular cognitive impairment, especially for mild deficits, as noted by the American Academy of Neurology 4

Advantages Over Other Cognitive Screening Tools

  • The MoCA is more sensitive to MCI than the MMSE, which lacks sensitivity for mild dementia or MCI, according to the National Institute on Aging 1
  • The MoCA includes assessment of executive function, which is often impaired in non-Alzheimer's dementias like Dementia with Lewy Bodies (DLB), as noted by the Lewy Body Dementia Association 2

Best Practices for Clinical Use

  • Combining the MoCA with functional screens and informant reports improves case-finding in people with cognitive difficulties, as recommended by the Alzheimer's Association 5
  • Serial cognitive assessments using the MoCA over time can help optimize accuracy for distinguishing patients with dementia from healthy controls, according to the American Academy of Neurology 1